How clinical research is coming home.

Summer camp at My Piece of the Puzzle — where challenged children meet children at risk

Meet your patients how and where they are

In this essay, I take a closer look how clinical trials are changing.

Change happens — just not how you expect

The classical supply chain model for clinical trials where sponsors went to CROs who went to sites who recruited patients is now changing.

The first driver was the pandemic.

Virtual nursing, remote nursing and Telehealth providers grew and developed rapidly during the pandemic. The adoption of remote and virtual care spilled over from primary care to clinical trials. Patients no longer need to leave home and nurses can come directly to the patients’ homes to test and monitor the patient.

The second driver are new operational models.

There are now new operational models for delivering clinical trials to patients. This is in contrast to current models of bringing patients to sites to investigators to CRO to sponsors. PharmaKon is one clinical research consultancy changing rules by changing their model of clinical operations.

The third driver of change is a return to patient-centric

From Hippocrates to Maimonides, making the patient the focus of care was always the starting point for a physician. Somehow — the clinical trial industry lost its way and started referring to patients as subjects not people.

OK, so not everyone is a generation Y living on the West Coast

Consumer technology used in digital health can be applied in clinical trials to meet patients where they are and tackle these challenges if we patient-centric design and not patient-centric lip-service.

In summary

We need to do patient-centric clinical research just as we need to do patient-centric medicine.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Danny Lieberman

Danny Lieberman

I am a physicist by training, serious amateur musician and everyday biker. Working in cybersecurity and AI-driven monitoring of clinical trials.